Redo TAVI: how to treat different TAVI platforms when they fail?

In this #europcr 2025 interview, Tanja Rudolph, Dan Blackman, and Radoslaw Parma explore the crucial aspects of repeat transcatheter valve replacement. They dive into the risks of coronary obstruction, the importance of preserving coronary access, and strategies to optimise hemodynamics despite higher residual gradients. The discussion also covers how the index TAVR device impacts outcomes and why CT screening is essential in planning. Tune in to get a clear picture of the current evidence and what new data is just around the corner. Hosted on Acast. See acast.com/privacy for more information.